
Inspection Points for AI Medical Devices: Centering on Lifecycle Traceability and Risk Control of Data and Algorithms
NMPA Center for Drug Inspection issued the “Inspection Points for Artificial Intelligence Medical Devices (Draft)” for feedback. Feedbacks need to be submitted by October 28,



